EL vs TBPH · rev $15.05B vs P/E 7.5, rev $38.4M
Estee Lauder Companies Inc (EL) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
EL currently screens at market cap $31.92B. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the EL and TBPH stock pages for the full models.
Not investment advice.